Heart valve study tests if fish oil derivative can harden progress
NCT ID NCT06466278
Summary
This study is testing whether a medication called icosapent ethyl can slow the progression of aortic valve stenosis, a condition where the heart's main valve narrows. It will involve about 110 adults over 50 with mild to moderate disease. The main goal is to see if the treatment reduces the buildup of calcium in the valve over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Academic Medical Center
Amsterdam, 1105AZ, Netherlands
Conditions
Explore the condition pages connected to this study.